Guidelines for detection and management of hyperbilirubinemia in term and late preterm newborns (≥35 weeks gestational age).

Hyperbilirubinemia is a common condition and is usually benign in term and late preterm newborns. Developing a standardized approach for all newborns to prevent, identify, and manage those with clinically significant hyperbilirubinemia will minimize the potential risks of long-term neurological sequelae from acute bilirubin encephalopathy and kernicterus. This statement provides recommendations on universal screening, risk factors assessment, and approaches to hyperbilirubinemia treatment, investigations, and monitoring.